A Single-Dose, Open-Label, Three Way Crossover, Randomized, Pilot Availability Study of Midazolam Comparing Intranasal Administration to Intravenous and Intramuscular Administration in Healthy Human Volunteers (MZ0001)

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/00 → 2/28/02

Funding

  • Inhalation Technology Inc: $117,821.00